2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Sell
25
LAB Quote, Financials, Valuation and Earnings
Last price:
$1.01
Seasonality move
:
3.47%
Day range:
$1.01 - $1.07
52-week range:
$0.92 - $2.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.23x
P/B ratio:
0.80x
Volume:
1.1M
Avg. volume:
1.4M
1-year change:
-60.55%
Market cap:
$364.9M
Revenue:
$174.4M
EPS (TTM):
-$0.35
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $138.1M | $130.6M | $97.9M | $106.3M | $174.4M | |
| Revenue Growth (YoY) | 17.83% | -5.48% | -24.99% | 8.57% | 64.03% | |
| Cost of Revenues | $54.8M | $61.2M | $60.9M | $55.9M | $90.2M | |
| Gross Profit | $83.3M | $69.4M | $37.1M | $50.5M | $84.3M | |
| Gross Profit Margin | 60.32% | 53.13% | 37.83% | 47.44% | 48.31% | |
| R&D Expenses | $36.5M | $37.9M | $37.4M | $25.9M | $62.4M | |
| Selling, General & Admin | $97.9M | $98.9M | $102.3M | $87.5M | $156.6M | |
| Other Inc / (Exp) | $507K | $7.6M | -$88.2M | -$12.2M | -$20.4M | |
| Operating Expenses | $134.4M | $136.8M | $139.7M | $113.5M | $219M | |
| Operating Income | -$51M | -$67.5M | -$102.6M | -$63M | -$134.8M | |
| Net Interest Expenses | $3.6M | $3.8M | $2.1M | $4.6M | -- | |
| EBT. Incl. Unusual Items | -$54.1M | -$63.7M | -$192.9M | -$74.2M | -$138.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.1M | -$4.4M | -$2.8M | $452K | $573K | |
| Net Income to Company | -$53M | -$59.2M | -$190.1M | -$74.7M | -$138.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$53M | -$59.2M | -$190.1M | -$74.7M | -$138.9M | |
| Basic EPS (Cont. Ops) | -$0.74 | -$0.78 | -$2.43 | -$0.94 | -$0.52 | |
| Diluted EPS (Cont. Ops) | -$0.74 | -$0.78 | -$2.43 | -$0.94 | -$0.52 | |
| Weighted Average Basic Share | $72M | $75.8M | $78.3M | $79.2M | $353.2M | |
| Weighted Average Diluted Share | $72M | $75.8M | $78.3M | $79.2M | $353.2M | |
| EBITDA | -$34.6M | -$44.3M | -$173.6M | -$54.5M | -$118.1M | |
| EBIT | -$50.5M | -$59.8M | -$188.6M | -$69.6M | -$135M | |
| Revenue (Reported) | $138.1M | $130.6M | $97.9M | $106.3M | $174.4M | |
| Operating Income (Reported) | -$51M | -$67.5M | -$102.6M | -$63M | -$134.8M | |
| Operating Income (Adjusted) | -$50.5M | -$59.8M | -$188.6M | -$69.6M | -$135M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $32.8M | $26.5M | $25.1M | $45.5M | $40.8M | |
| Revenue Growth (YoY) | 18.75% | -19.18% | -5.23% | 81.3% | -10.42% | |
| Cost of Revenues | $13.8M | $14.3M | $12.8M | $21.4M | $21.1M | |
| Gross Profit | $19M | $12.2M | $12.3M | $24.2M | $19.7M | |
| Gross Profit Margin | 58.06% | 46.17% | 48.89% | 53.11% | 48.39% | |
| R&D Expenses | $10.8M | $8.9M | $6.4M | $16M | $11.3M | |
| Selling, General & Admin | $27.6M | $30.9M | $21.3M | $46.9M | $38.7M | |
| Other Inc / (Exp) | -$285K | -$48.3M | -$1.2M | $1.5M | $1.2M | |
| Operating Expenses | $38.4M | $39.7M | $27.7M | $62.9M | $50M | |
| Operating Income | -$19.3M | -$27.5M | -$15.4M | -$38.7M | -$30.3M | |
| Net Interest Expenses | $887K | $1M | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$20.5M | -$76.9M | -$16.6M | -$32M | -$26.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.7M | -$574K | $263K | $128K | -$151K | |
| Net Income to Company | -$18.8M | -$76.3M | -$16.8M | -$32.2M | -$26M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$18.8M | -$76.3M | -$16.8M | -$32.2M | -$26M | |
| Basic EPS (Cont. Ops) | -$0.25 | -$0.99 | -$0.21 | -$0.27 | -$0.07 | |
| Diluted EPS (Cont. Ops) | -$0.25 | -$0.99 | -$0.21 | -$0.27 | -$0.07 | |
| Weighted Average Basic Share | $74.7M | $77M | $79.1M | $294.1M | $378.2M | |
| Weighted Average Diluted Share | $74.7M | $77M | $79.1M | $294.1M | $378.2M | |
| EBITDA | -$15.7M | -$71.9M | -$11.8M | -$25.8M | -$22M | |
| EBIT | -$19.6M | -$75.8M | -$15.4M | -$31M | -$26.2M | |
| Revenue (Reported) | $32.8M | $26.5M | $25.1M | $45.5M | $40.8M | |
| Operating Income (Reported) | -$19.3M | -$27.5M | -$15.4M | -$38.7M | -$30.3M | |
| Operating Income (Adjusted) | -$19.6M | -$75.8M | -$15.4M | -$31M | -$26.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $143.3M | $124.3M | $96.6M | $126.8M | $169.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $57.4M | $61.7M | $59.5M | $64.5M | $89.9M | |
| Gross Profit | $85.9M | $62.6M | $37.1M | $62.3M | $79.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $38.5M | $36.1M | $34.9M | $35.4M | $57.8M | |
| Selling, General & Admin | $102.8M | $102.2M | $97.9M | $113.2M | $148.4M | |
| Other Inc / (Exp) | $1M | -$40.4M | -$35.8M | -$9.4M | -$20.8M | |
| Operating Expenses | $141.3M | $138.2M | $132.9M | $148.6M | $206.1M | |
| Operating Income | -$55.4M | -$75.6M | -$95.8M | -$86.3M | -$126.3M | |
| Net Interest Expenses | $3.6M | $4M | $1M | -- | -- | |
| EBT. Incl. Unusual Items | -$57.9M | -$120M | -$132.6M | -$89.7M | -$132.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$2.1M | -$3.3M | -$2M | $317K | $294K | |
| Net Income to Company | -$55.9M | -$116.7M | -$130.7M | -$90M | -$132.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$55.9M | -$116.7M | -$130.7M | -$90M | -$132.8M | |
| Basic EPS (Cont. Ops) | -$0.75 | -$1.52 | -$1.66 | -$1.01 | -$0.35 | |
| Diluted EPS (Cont. Ops) | -$0.75 | -$1.52 | -$1.66 | -$1.01 | -$0.35 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$38.6M | -$100.4M | -$113.5M | -$68.5M | -$106.6M | |
| EBIT | -$54.4M | -$116.1M | -$128.2M | -$85.2M | -$122.4M | |
| Revenue (Reported) | $143.3M | $124.3M | $96.6M | $126.8M | $169.7M | |
| Operating Income (Reported) | -$55.4M | -$75.6M | -$95.8M | -$86.3M | -$126.3M | |
| Operating Income (Adjusted) | -$54.4M | -$116.1M | -$128.2M | -$85.2M | -$122.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $32.8M | $26.5M | $25.1M | $45.5M | $40.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $13.8M | $14.3M | $12.8M | $21.4M | $21.1M | |
| Gross Profit | $19M | $12.2M | $12.3M | $24.2M | $19.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $10.8M | $8.9M | $6.4M | $16M | $11.3M | |
| Selling, General & Admin | $27.6M | $30.9M | $21.3M | $46.9M | $38.7M | |
| Other Inc / (Exp) | -$285K | -$48.3M | -$1.2M | $1.5M | $1.2M | |
| Operating Expenses | $38.4M | $39.7M | $27.7M | $62.9M | $50M | |
| Operating Income | -$19.3M | -$27.5M | -$15.4M | -$38.7M | -$30.3M | |
| Net Interest Expenses | $887K | $1M | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$20.5M | -$76.9M | -$16.6M | -$32M | -$26.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.7M | -$574K | $263K | $128K | -$151K | |
| Net Income to Company | -$18.8M | -$76.3M | -$16.8M | -$32.2M | -$26M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$18.8M | -$76.3M | -$16.8M | -$32.2M | -$26M | |
| Basic EPS (Cont. Ops) | -$0.25 | -$0.99 | -$0.21 | -$0.27 | -$0.07 | |
| Diluted EPS (Cont. Ops) | -$0.25 | -$0.99 | -$0.21 | -$0.27 | -$0.07 | |
| Weighted Average Basic Share | $74.7M | $77M | $79.1M | $294.1M | $378.2M | |
| Weighted Average Diluted Share | $74.7M | $77M | $79.1M | $294.1M | $378.2M | |
| EBITDA | -$15.7M | -$71.9M | -$11.8M | -$25.8M | -$22M | |
| EBIT | -$19.6M | -$75.8M | -$15.4M | -$31M | -$26.2M | |
| Revenue (Reported) | $32.8M | $26.5M | $25.1M | $45.5M | $40.8M | |
| Operating Income (Reported) | -$19.3M | -$27.5M | -$15.4M | -$38.7M | -$30.3M | |
| Operating Income (Adjusted) | -$19.6M | -$75.8M | -$15.4M | -$31M | -$26.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $68.5M | $28.5M | $81.3M | $51.7M | $166.7M | |
| Short Term Investments | -- | -- | $84.5M | $63.2M | $126.1M | |
| Accounts Receivable, Net | $25.4M | $18.3M | $17.3M | $19.7M | $33.6M | |
| Inventory | $19.7M | $20.8M | $21.5M | $20.5M | $40.7M | |
| Prepaid Expenses | $4M | -- | -- | -- | -- | |
| Other Current Assets | -- | $4.5M | $4.3M | $3.1M | $8.7M | |
| Total Current Assets | $117.7M | $72.1M | $208.8M | $158.2M | $375.9M | |
| Property Plant And Equipment | $55.6M | $65.2M | $59.5M | $54.9M | $71.4M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $106.6M | $106.4M | $106.3M | $106.3M | $111.3M | |
| Other Intangibles | $42.2M | $29.2M | $12.6M | $1.4M | $29M | |
| Other Long-Term Assets | $2.7M | $2.4M | $3.1M | $2.3M | $24.8M | |
| Total Assets | $324.8M | $275.2M | $390.3M | $323.1M | $612.3M | |
| Accounts Payable | $9.2M | $10.6M | $7.9M | $9.2M | $12.3M | |
| Accrued Expenses | $11.9M | $8.7M | $10.2M | $6.6M | $12.5M | |
| Current Portion Of Long-Term Debt | -- | -- | $2.1M | $59.5M | -- | |
| Current Portion Of Capital Lease Obligations | $3M | $3.1M | $3.7M | $4.3M | $6.2M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $54.2M | $49.6M | $43.4M | $109.3M | $65.9M | |
| Long-Term Debt | $54.2M | $64.2M | $62.8M | $4M | $299K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $185.7M | $180.6M | $471.8M | $471.1M | $140.6M | |
| Common Stock | $75K | $77K | $80K | $83K | $396K | |
| Other Common Equity Adj | $112K | -$907K | -$1.9M | -$2.2M | $1.2M | |
| Common Equity | $139.1M | $94.6M | -$81.5M | -$148.1M | $471.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $139.1M | $94.6M | -$81.5M | -$148.1M | $471.7M | |
| Total Liabilities and Equity | $324.8M | $275.2M | $390.3M | $323.1M | $612.3M | |
| Cash and Short Terms | $68.5M | $28.5M | $165.8M | $114.9M | $292.9M | |
| Total Debt | $54.2M | $71M | $64.9M | $63.5M | $299K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $49.7M | $30M | $113.7M | $287.1M | $150.9M | |
| Short Term Investments | -- | -- | $40.9M | $175.2M | $107.2M | |
| Accounts Receivable, Net | $15.4M | $15.4M | $14.5M | $36M | $30.6M | |
| Inventory | $21.9M | $23.2M | $22.5M | $40.4M | $42.1M | |
| Prepaid Expenses | $9.3M | $4.5M | -- | -- | -- | |
| Other Current Assets | -- | -- | $3.4M | $8.9M | $8.4M | |
| Total Current Assets | $96.3M | $73.2M | $194.9M | $547.6M | $344M | |
| Property Plant And Equipment | $61M | $64.1M | $58M | $77.8M | $71M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $106.5M | $106.3M | $106.3M | $106.3M | $111.7M | |
| Other Intangibles | $38.8M | $26M | $10.2M | $24.8M | $28.1M | |
| Other Long-Term Assets | $2.6M | $2.4M | $2.3M | $16.9M | $24.8M | |
| Total Assets | $305.2M | $271.9M | $371.7M | $777.7M | $579.6M | |
| Accounts Payable | $12.6M | $12.5M | $6.1M | $13.1M | $11.8M | |
| Accrued Expenses | $18.7M | $11.3M | $9.3M | $16.1M | $11.5M | |
| Current Portion Of Long-Term Debt | -- | -- | $3.3M | $54.7M | -- | |
| Current Portion Of Capital Lease Obligations | $3M | $3.2M | $3.8M | $5.8M | $6.3M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $53.5M | $47.2M | $43.8M | $121.6M | $56.2M | |
| Long-Term Debt | $53.8M | $100M | $61.7M | $299K | $299K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $182.3M | $249.8M | $468.8M | $200.4M | $125M | |
| Common Stock | $75K | $77K | $80K | $387K | $397K | |
| Other Common Equity Adj | -$331K | -$1.1M | -$1.3M | -$1.8M | $1.2M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $122.9M | $22.1M | -$97.2M | $577.3M | $454.6M | |
| Total Liabilities and Equity | $305.2M | $271.9M | $371.7M | $777.7M | $579.6M | |
| Cash and Short Terms | $49.7M | $30M | $154.5M | $462.3M | $258.1M | |
| Total Debt | $53.8M | $100M | $65.1M | $55M | $299K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$53M | -$59.2M | -$190.1M | -$74.7M | -$138.9M | |
| Depreciation & Amoritzation | $15.9M | $15.6M | $15M | $15.2M | $16.9M | |
| Stock-Based Compensation | $14.5M | $16.1M | $14.9M | $13.1M | $31.7M | |
| Change in Accounts Receivable | -$7.6M | $6.7M | $1.1M | -$3M | $9M | |
| Change in Inventories | -$8.6M | -$4.8M | -$8.5M | -$4.9M | -$9.9M | |
| Cash From Operations | -$15.4M | -$44.1M | -$89.4M | -$43.3M | -$143.5M | |
| Capital Expenditures | $12.7M | $13.3M | $3.8M | $2.8M | $8.4M | |
| Cash Acquisitions | -$5.2M | -- | -- | -- | $278.6M | |
| Cash From Investing | $40M | -$11.9M | -$88.1M | $20.2M | $363.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $16.8M | $25M | -- | -- | |
| Long-Term Debt Repaid | -- | -$501K | -$6.8M | -$2.1M | -$63.2M | |
| Repurchase of Common Stock | -- | -- | -$563K | -$5.4M | -$40.5M | |
| Other Financing Activities | -$1.1M | -$1.9M | -$12.8M | -$139K | -$1M | |
| Cash From Financing | $20.9M | $16M | $230.8M | -$6.8M | -$102.6M | |
| Beginning Cash (CF) | $23.7M | $69.5M | $29.5M | $82.3M | $52.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $45.4M | -$40M | $53.3M | -$29.9M | $117.1M | |
| Ending Cash (CF) | $69.5M | $29.5M | $82.3M | $52.5M | $168.8M | |
| Levered Free Cash Flow | -$28.1M | -$57.3M | -$93.2M | -$46.1M | -$151.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$18.8M | -$76.3M | -$16.8M | -$32.2M | -$26M | |
| Depreciation & Amoritzation | $3.9M | $4M | $3.7M | $5.2M | $4.2M | |
| Stock-Based Compensation | $3.7M | $4M | $3.1M | $11.6M | $9M | |
| Change in Accounts Receivable | $9.8M | $2.9M | $3M | $686K | -$2M | |
| Change in Inventories | -$2.9M | -$3.6M | -$1.1M | -$6.3M | -$3.8M | |
| Cash From Operations | -$12.9M | -$15.6M | -$8.5M | -$62.5M | -$30.3M | |
| Capital Expenditures | $6.9M | $868K | $1M | $781K | $5.1M | |
| Cash Acquisitions | -- | -- | -- | $280M | -- | |
| Cash From Investing | -$4.9M | -$868K | $43.2M | $318.1M | $14.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $25M | -- | -- | -- | |
| Long-Term Debt Repaid | -$501K | -$6.8M | -- | -$8.2M | -- | |
| Repurchase of Common Stock | -- | -- | -$2.5M | -$11.1M | -- | |
| Other Financing Activities | -$525K | -$87K | -$92K | -$562K | -$46K | |
| Cash From Financing | -$1M | $18.1M | -$2.6M | -$19.7M | -$46K | |
| Beginning Cash (CF) | $69.5M | $29.5M | $82.3M | $52.5M | $168.8M | |
| Foreign Exchange Rate Adjustment | $74K | -$85K | $23K | -$21K | $357K | |
| Additions / Reductions | -$18.9M | $1.6M | $32.1M | $235.9M | -$15.7M | |
| Ending Cash (CF) | $50.8M | $31M | $114.5M | $288.3M | $153.5M | |
| Levered Free Cash Flow | -$19.8M | -$16.5M | -$9.5M | -$63.3M | -$35.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$55.9M | -$116.7M | -$130.7M | -$90M | -$132.8M | |
| Depreciation & Amoritzation | $15.8M | $15.6M | $14.7M | $16.7M | $15.8M | |
| Stock-Based Compensation | $15.8M | $16.5M | $14M | $21.6M | $29.1M | |
| Change in Accounts Receivable | -$2.5M | -$197K | $1.2M | -$5.3M | $6.3M | |
| Change in Inventories | -$9.3M | -$5.4M | -$6M | -$10.2M | -$7.4M | |
| Cash From Operations | -$24M | -$46.8M | -$82.3M | -$97.3M | -$111.3M | |
| Capital Expenditures | $18.6M | $7.2M | $4M | $2.6M | $12.6M | |
| Cash Acquisitions | -- | -- | -- | $280M | -$1.4M | |
| Cash From Investing | $17.6M | -$7.9M | -$44.1M | $295.2M | $59.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $41.8M | -- | -- | -- | |
| Long-Term Debt Repaid | -$501K | -$6.8M | -- | -$10.3M | -$55M | |
| Repurchase of Common Stock | -- | -- | -$3M | -$14M | -$29.4M | |
| Other Financing Activities | -$1.2M | -$1.4M | -$12.8M | -$609K | -$488K | |
| Cash From Financing | $20.3M | $35.1M | $210.1M | -$24M | -$82.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $13.9M | -$19.6M | $83.8M | $173.9M | -$134.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$42.6M | -$54M | -$86.2M | -$99.9M | -$123.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$18.8M | -$76.3M | -$16.8M | -$32.2M | -$26M | |
| Depreciation & Amoritzation | $3.9M | $4M | $3.7M | $5.2M | $4.2M | |
| Stock-Based Compensation | $3.7M | $4M | $3.1M | $11.6M | $9M | |
| Change in Accounts Receivable | $9.8M | $2.9M | $3M | $686K | -$2M | |
| Change in Inventories | -$2.9M | -$3.6M | -$1.1M | -$6.3M | -$3.8M | |
| Cash From Operations | -$12.9M | -$15.6M | -$8.5M | -$62.5M | -$30.3M | |
| Capital Expenditures | $6.9M | $868K | $1M | $781K | $5.1M | |
| Cash Acquisitions | -- | -- | -- | $280M | -- | |
| Cash From Investing | -$4.9M | -$868K | $43.2M | $318.1M | $14.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $25M | -- | -- | -- | |
| Long-Term Debt Repaid | -$501K | -$6.8M | -- | -$8.2M | -- | |
| Repurchase of Common Stock | -- | -- | -$2.5M | -$11.1M | -- | |
| Other Financing Activities | -$525K | -$87K | -$92K | -$562K | -$46K | |
| Cash From Financing | -$1M | $18.1M | -$2.6M | -$19.7M | -$46K | |
| Beginning Cash (CF) | $69.5M | $29.5M | $82.3M | $52.5M | $168.8M | |
| Foreign Exchange Rate Adjustment | $74K | -$85K | $23K | -$21K | $357K | |
| Additions / Reductions | -$18.9M | $1.6M | $32.1M | $235.9M | -$15.7M | |
| Ending Cash (CF) | $50.8M | $31M | $114.5M | $288.3M | $153.5M | |
| Levered Free Cash Flow | -$19.8M | -$16.5M | -$9.5M | -$63.3M | -$35.3M | |
Get LAB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LAB
Sector
P/E ratio
--
24.37x
PEG ratio
--
0.00x
P/B ratio
0.80x
1.74x
Price / LTM sales
2.23x
1.65x
Growth Metrics
LAB
Sector
Revenue growth
-10.42%
5.12%
Earnings growth
--
7.46%
Revenue (5-year growth)
8.27%
8.25%
Earnings forecast
-$0.04
-$0.20
Profitability
LAB
Sector
Profitability FY 2024
$84.3M
$51.2M
Return on invested capital
-24.87%
-14.95%
Return on assets
-19.76%
-12.07%
Return on equity
-26.52%
-17.16%
Earnings Date
Last Earnings Date
May
6
Next Earnings Date
Jul
31
Estimated Next Earnings Date
Aug
5
Balance Sheet
LAB
Sector
Total cash
$258.1M
$38.3M
Short term investments
$126.1M
$33.2M
Total assets
$612.3M
$118.2M
Long term debt
$299K
$8.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Where Will Dell Stock Be in 5 Years?
So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
